Table 1 (abstract P420)
From: Efficacy and safety of enoxaparin as deep vein thrombosis prophylaxis in critically ill patients
Type of case | ICU LOS (days) | APACHE II | Predicted mortality (%) |
|---|---|---|---|
Total cases on enoxaparine | 5.29 ± 7.3 | 16.7 ± 10.5 | 28.4 ± 23.7 |
Low platelets cases | 11.75 ± 9.7 | 23 ± 2.3 | 48.75 ± 11.18 |
Major bleeding cases | 13.5 ± 13.1 | 22.4 ± 17.4 | 30 ± 17.5 |